Literature DB >> 15568972

Genetic control of retrovirus susceptibility in mammalian cells.

Stephen P Goff1.   

Abstract

Host cellular genes can have profound effects on retrovirus replication. Many of these genes encode restriction factors that block virus infection; others encode positive factors that are exploited by the viruses. Recently, a number of such genes have been cloned and characterized, bringing into sharper focus the mechanisms and pathways exploited by these viruses. The major host factors involved in the early phase of the viral life cycle are discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15568972     DOI: 10.1146/annurev.genet.38.072902.094136

Source DB:  PubMed          Journal:  Annu Rev Genet        ISSN: 0066-4197            Impact factor:   16.830


  39 in total

1.  An intrinsic host defense against HIV-1 integration?

Authors:  Paul D Bieniasz
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

2.  High-throughput, library-based selection of a murine leukemia virus variant to infect nondividing cells.

Authors:  Julie H Yu; David V Schaffer
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 3.  Host factors that control long terminal repeat retrotransposons in Saccharomyces cerevisiae: implications for regulation of mammalian retroviruses.

Authors:  Patrick H Maxwell; M Joan Curcio
Journal:  Eukaryot Cell       Date:  2007-05-11

4.  Two regions within the amino-terminal half of APOBEC3G cooperate to determine cytoplasmic localization.

Authors:  Mark D Stenglein; Hiroshi Matsuo; Reuben S Harris
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

5.  Nucleic acid recognition orchestrates the anti-viral response to retroviruses.

Authors:  Spyridon Stavrou; Kristin Blouch; Swathi Kotla; Antonia Bass; Susan R Ross
Journal:  Cell Host Microbe       Date:  2015-03-26       Impact factor: 21.023

6.  Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity.

Authors:  David Perez-Caballero; Theodora Hatziioannou; Annie Yang; Simone Cowan; Paul D Bieniasz
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

7.  Removal of arginine 332 allows human TRIM5alpha to bind human immunodeficiency virus capsids and to restrict infection.

Authors:  Yuan Li; Xing Li; Matthew Stremlau; Mark Lee; Joseph Sodroski
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

8.  Cyclophilin A-dependent restriction to capsid N121K mutant human immunodeficiency virus type 1 in a broad range of cell lines.

Authors:  Taichiro Takemura; Miyako Kawamata; Miho Urabe; Tsutomu Murakami
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

9.  Inhibition of HIV-1 replication by small interfering RNAs directed against glioma pathogenesis related protein (GliPR) expression.

Authors:  Gianni Capalbo; Thea Müller-Kuller; Ursula Dietrich; Dieter Hoelzer; Oliver G Ottmann; Urban J Scheuring
Journal:  Retrovirology       Date:  2010-03-31       Impact factor: 4.602

10.  Mode of transmission affects the sensitivity of human immunodeficiency virus type 1 to restriction by rhesus TRIM5alpha.

Authors:  Max W Richardson; Richard G Carroll; Matthew Stremlau; Nikolay Korokhov; Laurent M Humeau; Guido Silvestri; Joseph Sodroski; James L Riley
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.